To the full analysis
Buyback calculator for Castle Biosciences
Castle Biosciences stock: key metrics
CSTLCastle Biosciences had an operating margin of −12.4% and a return on invested capital (ROIC) of −17% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2017 | 64.2% | −79.2% | −89.9% |
| 2018 | 76.8% | −16.8% | −27.9% |
| 2019 | 85.9% | 14.1% | 10.2% |
| 2020 | 84.5% | −10.4% | −16.4% |
| 2021 | 83.2% | −42.6% | −33.3% |
| 2022 | 76.6% | −53.2% | −49.0% |
| 2023 | 79.5% | −30.9% | −26.1% |
| 2024 | 81.9% | 2.6% | 5.5% |
| 2025 | 79.4% | −12.4% | −7.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2017 | 86.7% | no data | −100.0% |
| 2018 | 63.2% | −46.4% | −28.4% |
| 2019 | 6.2% | 11.5% | 4.4% |
| 2020 | −2.5% | −2.0% | −2.3% |
| 2021 | −7.6% | −65.9% | −6.8% |
| 2022 | −16.8% | −47.1% | −15.0% |
| 2023 | −14.7% | −33.8% | −12.7% |
| 2024 | 4.0% | 4.2% | 3.4% |
| 2025 | −5.1% | −17.0% | −4.2% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 9 May 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.